1093 — CSPC Pharmaceutical Cashflow Statement
0.000.00%
- HK$91.14bn
- HK$82.82bn
- CNY29.01bn
- 90
- 39
- 34
- 57
Annual cashflow statement for CSPC Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,391 | 6,847 | 7,582 | 7,389 | 5,579 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,078 | -545 | -465 | 16.2 | 130 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 619 | -2,529 | -536 | -4,341 | -2,510 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,740 | 4,637 | 7,627 | 4,179 | 4,535 |
| Capital Expenditures | -1,577 | -1,758 | -2,723 | -1,893 | -2,679 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -553 | 1,121 | -4,073 | 2,759 | -1,179 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,130 | -637 | -6,796 | 866 | -3,858 |
| Financing Cash Flow Items | -20 | -20.2 | 342 | 792 | 194 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,471 | -2,197 | -1,904 | -2,560 | -5,253 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,141 | 1,800 | -1,059 | 2,490 | -4,573 |